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Interpreting a DXA Scan in Clinical Practice 
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Rheumatology Department, Military Hospital Mohammed V, Rabat, 
Morocco 
1. Introduction 
Osteoporosis is a metabolic bone disorder characterized by low bone mass and 
microarchitectural deterioration, with a subsequent increase in bone fragility and 
susceptibility to fracture. Dual-energy x-ray absorptiometry (DXA) is recognized as the 
reference method to measure bone mineral density (BMD) with acceptable accuracy errors 
and good precision and reproducibility(Blake and Fogelman 2007). The World Health 
Organization (WHO) has established DXA as the best densitometric technique for assessing 
BMD in postmenopausal women and based the definitions of osteopenia and osteoporosis 
on its results (table 1)(Kanis 1994; Kanis, Borgstrom et al. 2005). DXA allows accurate 
diagnosis of osteoporosis, estimation of fracture risk, and monitoring of patients undergoing 
treatment. Additional features of DXA include measurement of BMD at multiple skeletal 
sites, safety of performance, short investigation time, and ease of use(Hans, Downs et al. 
2006; Lewiecki, Binkley et al. 2006). A DXA measurement can be completed in about 5 
minutes with minimal radiation exposure (about one tenth that of a standard chest x-ray for 
a quick hips and spine exam). 
 
Diagnosis T-score 
Normal >–1.0 
Osteopenia <–1.0, >–2.5 
Osteoporosis <–2.5 
Severe osteoporosis <–2.5 plus fragility fractures
Table 1. WHO Osteoporosis Classification 
2. Principle of DXA scanning 
As with many other diagnostic examinations, DXA scans should be critically assessed by the 
interpreting physician and densitometrist for abnormalities that may affect BMD 
measurements. In clinical practice, recognition of diverse artifacts and disease processes that 
may influence BMD results can be of major importance in the optimal interpretation of DXA 
scans(Roux 1998). Physicians not directly involved in the performance and interpretation of 
DXA should be familiar enough to detect common positioning and scanning problems, to 
know what should appear on a report, what questions to ask if the necessary information is 
not on the report, how to apply the results in patient management, and when to do and how 
to interpret a second measurement to monitor treatment(Watts 2004).  
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Several different types of DXA systems are available, but they all operate on similar 
principles. A radiation source is aimed at a radiation detector placed directly opposite the 
site to be measured. The patient is placed on a table in the path of the radiation beam. The 
source/detector assembly is then scanned across the measurement region. The attenuation 
of the radiation beam is determined and is related to the BMD (Blake and Fogelman 2002; 
Blake and Fogelman 2003).  
Because DXA scanners use two X-ray energies in the presence of three types of tissue (bone 
mineral, lean tissue and adipose tissue), there are considerable errors arising from the 
inhomogeneous distribution of adipose tissue in the human body(Tothill and Avenell 1994) 
(which can be studied either through cadaver studies(Svendsen, Hassager et al. 1995), CT 
imaging to delineate the distribution of adipose tissue external to bone(Kuiper, van Kuijk et 
al. 1996; Lee, Wren et al. 2007) or MRI to measure the percentage of marrow fat inside 
bone(Griffith, Yeung et al. 2006)). These studies suggest BMD measurement errors of around 
5 to 8%. 
DXA technology can measure virtually any skeletal site, but clinical use has been 
concentrated on the lumbar spine, proximal femur, forearm, and total body (Hans, Downs et 
al. 2006). DXA systems are available as either full table systems (capable of multiple skeletal 
measurements, including the spine and hip) or as peripheral systems (limited to measuring 
the peripheral skeleton). Because of their versatility, and the ability to measure the skeletal 
sites of greatest clinical interest, full table DXA systems are the current clinical choice for 
osteoporosis assessment. Peripheral DXA systems, portable and less expensive than full 
table systems, are more frequently used as screening and early risk assessment tools; they 
cannot be used for treatments follow-up. Spine and proximal femur scans represent the 
majority of the clinical measurements performed using DXA. Most full table DXA systems 
are able to perform additional scans, including lateral spine BMD measurements, body 
composition study, assessment of vertebral fractures, measurements of children and infants, 
assessment of bone around prosthetic implants, small-animal studies and measurements of 
excised bone specimens. However, for children measurement, the exam should be 
undertaken by clinicians skilled in interpretation of scans in children in centers that have an 
adapted paediatric software. 
Early DXA systems used a pencil beam geometry and a single detector, which was scanned 
across the measurement region. Modern full table DXA scanners use a fan-beam source and 
multiple detectors, which are swept across the measurement region. Fan beam provides the 
advantage of decreased scan times compared to single-beam systems, but these machines 
typically cost more because of the need for multiple X-ray detectors. Fan-beam systems use 
either a single-view or multiview mode to image the skeleton (Lewiecki and Borges 2006).  
In clinical practice, BMD measurements are widely used to diagnose osteoporosis and 
measurement in bone mass are commonly used as a surrogate for fracture risk (Price, 
Walters et al. 2003). BMD is the measured parameter, and allows the calculation of the bone 
mineral content (BMC) in grams and the two-dimensional projected area in cm2 of the 
bone(s) being measured; thus the units of BMD are g/cm2. The BMD values (in g/cm2) are not 
used for diagnosing osteoporosis. Instead, a working group of the WHO proposed to define 
osteoporosis on the basis of the T-score (which is the difference between the measured BMD 
and the mean value of young adults, expressed in standard deviations (SD) for a normal 
population of the same gender and ethnicity)(Watts 2004). Despite its limitations; this 
definition, which concerns only postmenopausal women and men over 50, is currently applied 
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worldwide. Thus, the WHO diagnostic criteria for osteoporosis define osteoporosis in terms of 
a T-score below −2.5 and osteopenia when T-score is between -2.5 and -1. 
The T-score is calculated using the formula: (patient’s BMD - young normal mean)/SD of 
young normal. For example, if a patient has a BMD of 0.700 g/cm2, the young normal mean 
is 1.000 g/cm2, and the young normal standard deviation is 0.100 g/cm2, then this patient’s 
T-score would be (0.700 - 1.000)/0.100, or –0.300/0.100, or –3.0(Watts 2004). A T-score of 0 is 
equal to the young normal mean value, -1.0 is 1 SD low, -2.0 is 2 SD low, etc. Although the 
WHO classification was not intended to be applied to individual patients, it works well to 
define ‘‘normal’’ (T-score –1.0 and above) and ‘‘osteoporosis’’ (T-score –2.5 and below). 
Several large studies have shown an unacceptably high risk of fracture in post-menopausal 
women who have T-scores of –2.5 and below. Thus, this threshold is the cornerstone of the 
patient’s assessment. For the therapeutic decisions, however, other risk factors are 
considered such as prevalent fractures, age and low body mass index. 
In addition to the T-scores, DXA reports also provide Z-scores, which are calculated 
similarly to the T-score, except that the patient’s BMD is compared with an age-matched 
(and race- and gender-matched) mean, and the result expressed as a standard deviation 
score(Watts 2004). In premenopausal women, a low Z-score (below -2.0) indicates that bone 
density is lower than expected and should trigger a search for an underlying cause. 
3. Who should have a DXA measurement? 
Most official groups recommend screening healthy women for osteoporosis at age 65, and 
testing higher-risk women earlier(Baddoura, Awada et al. 2006). In Europe the 
recommendations are to screen for risk factors of osteoporosis and to perform BMD 
measurement in women with such risks. The International Society for Clinical Densitometry 
(ISCD) recommends screening men without risk factors for osteoporosis at age 70, and 
screening higher-risk men earlier. Risk factors include dementia, poor health, recent falls, 
prolonged immobilization, smoking, alcohol abuse, low body weight, history of fragility 
fracture in a first-degree relative, estrogen deficiency at an early age (<45 years), and steroid 
use for more than 3 months. Of course, BMD testing is an appropriate tool in the evaluation 
of patients who have diseases (e.g. hyperthyroidism, hyperparathyroidism, celiac disease, 
etc.) or use medications (e.g. glucocorticoids, GnRH agonists, aromatase inhibitors etc.) that 
might cause bone loss. Another indication is radiographic evidence of ‘‘osteopenia’’ or a 
vertebral fracture). 
Recently, many epidemiological studies have validated risk assessment indices for 
osteoporosis in women. The purpose of the risk assessment indices is not to diagnose 
osteoporosis or low BMD, but to identify women who are more likely to have low BMD 
(Hillier, Stone et al. 2007). Such indices, while not identifying all cases of osteoporosis, increase 
the efficiency of BMD measurement by focusing on subjects who are at increased risk 
(Cadarette, Jaglal et al. 2000; Gnudi and Sitta 2005; Salaffi, Silveri et al. 2005). The easiest to use 
in clinical practice is certainly the Osteoporosis Self-assessment Tool (OST). The calculated risk 
index is based on self-reported age and weight: [(weight in kilograms – age in years) × 0.2, 
truncated to an integer]. It was developed and validated in several studies in Asian and White 
women(Richy, Ethgen et al. 2004; El Maghraoui, Guerboub et al. 2007; El Maghraoui, Habbassi 
et al. 2007) and men (Adler, Tran et al. 2003; Ghazi, Mounach et al. 2007). 
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4. Site of measurement of BMD 
The ISCD recommends obtaining BMD measurements of the posteroanterior spine and 
hip(Leib, Binkley et al. 2006). The lateral spine and Ward's triangle region of the hip should 
not be used for diagnosis, because these sites overestimate osteoporosis and results can be 
false-positive. Evidence suggests that the femur (neck or total hip) is the optimum site for 
predicting the risk of hip fracture and the spine is the optimum site for monitoring response 
to treatment. Thus, many authors recommend hip measure alone for the fracture risk 
assessment(Kanis, Johnell et al. 2000; Kanis, Oden et al. 2001; Kanis 2002; Johnell, Kanis et al. 
2005; Kanis, Seeman et al. 2005; Arabi, Baddoura et al. 2007). In very obese patients, those 
with primary hyperparathyroidism, or those in whom the hip or the spine, or both, cannot 
be measured or interpreted, BMD may be measured in the forearm, using a 33% radius on 
the nondominant forearm. 
5. Interpreting a DXA scan 
The most important informations to check are the correct identification of the patient, his 
date of birth and also the sex and ethnicity which are mandatory to calculate T-scores. Sex is 
used by all manufacturers to calculate T-scores (i.e. T-scores for women are calculated using 
a female normative database, while T-scores for men are calculated using a male normative 
database). Although all manufacturers use race in calculating Z-scores, there is 
inconsistency in the way race is handled when calculating T-scores. Norland and Hologic 
are using race in calculating T-scores (i.e. T-scores for Caucasians are calculated using a 
Caucasian normative database, T-scores for Blacks are calculated using a normative 
database for Blacks); however, GE Lunar and recent Hologic machines use the database for 
young-normal Caucasians to calculate T-scores, regardless of the race of the subject. The 
ISCD recommends the latter approach for use in North America (Baim, Wilson et al. 2005) 
because using race-adjusted T-scores results in a similar prevalence of ‘‘osteoporosis’’ in 
every racial group, despite the fact that age-specific fracture rates can be very different. 
5.1 Positioning 
The main purpose of the DXA scan image is to check if the patient is positioned correctly, 
something that the technologist must determine before the patient leaves the testing centre. 
Positioning should also be doublechecked by the clinician who interprets the test(Roux 
1998). There is many available resources for BMD technologists and physicians training, 
such as ISCD or International Osteoporosis Foundation (IOF) courses. 
A scan with correct positioning of the spine is shown in Fig. 1a: the patient is straight on the 
table (spine is straight on the image), not rotated (spinous processes are centered), and 
centered in the field (roughly equal soft tissue fields on either side of the spine). Patients 
with scoliosis cannot be positioned with the spine straight on the table; moreover with 
severe scoliosis degenerative changes can occur that invalidate the spine measurement. The 
scan should extend up sufficiently far to include part of the lowest vertebra with ribs (which 
is usually T12) and low enough to show the pelvic brim (which is usually the level of the 
L4–L5 interspace). Most testing centers will elevate the patient’s knees with a foam block 
(hip at a 90° angle to the spine) to try to partially flatten the normal lumbar lordosis. For 
proper positioning of the hip, the patient should have the femur straight on the table (shaft 
parallel to the edge of the picture), with 15–25° of internal rotation, which can be achieved 
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by the use of positioning devices. Internal rotation may be improved by having the patient flex 
the foot before doing the internal rotation, and then relaxing the foot after the strap is in place. 
This amount of internal rotation presents the long axis of the femoral neck perpendicular to 
the X-ray beam, providing the greatest area and the lowest bone mineral content (and the 
lowest BMD), and is confirmed on the scan by seeing little or none of the lesser trochanter (Fig. 
1b)(Lekamwasam and Lenora 2003; 2004). If the desired amount of internal rotation cannot be 
achieved, as is often the case in patients with hip arthritis or short femoral necks, the 
technologist should place the patient comfortably in a position that is likely to be reproducible 
in a subsequent scan (Hamdy, Kiebzak et al. 2006; Lewiecki, Binkley et al. 2006).  
 
(a) 
        
                                                      (b)                                                                        (c) 
Fig. 1. Correct positioning and analysis of the L1–L4 spine (a) and the proximal femur 
(Lunar (b) and Hologic (c)). 
5.2 DXA scan analysis 
The software marks regions of interest in the spine and hip, but the technologist can and 
should make adjustments if needed. The spine region of interest consists of the L1 through 
L4 vertebrae (Fig. 1a). Correct placement of the top and bottom of the spine ‘‘box’’ is critical. 
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The intervertebral lines can be moved or angled, if necessary. There must be sufficient soft 
tissue on both sides of the spine; otherwise BMD will be under estimated. The hip regions of 
interest include the femoral neck, trochanter, and total hip (Fig. 1b). Ward’s region and the 
intertrochanteric region are not relevant (and can be deleted from the results reports. The 
default hip analysis includes a midline that must be placed correctly for the other sites to be 
identified correctly. The preferred position for the rectangular femoral neck box differs for 
the different manufacturers. For GE Lunar, the femoral neck box is located by the analysis 
program at the narrowest and lowest density section of the neck; typically this will be about 
half way between the femoral head and the trochanter (Fig. 1b). For Hologic the box is on 
the distal part of the femoral neck (Fig. 1c). This induces a large difference among these 2 
measurements, because of a gradient of BMD all along the femoral neck (the proximal being 
the highest, the distal being the lowest). Thus careful checking of the femoral neck box is 
mandatory. 
The image should be evaluated for artifacts (e.g. surgical clips, navel rings, barium sulphate, 
metal from zipper, coin, clip, or other metallic object) or local structural change (e.g. 
osteophytes, syndesmophytes, compression fractures, aortic calcification). Almost all 
artifacts and local structural change will spuriously elevate BMD(El Maghraoui 2004). This 
is especially true for spinal degenerative change, which can elevate spine BMD by 2, 3, or 
more T-score. In the spine, absent bone (laminectomy or spina bifida) or vertebral rotation 
(idiopathic scoliosis) will spuriously lower BMD. All evaluable vertebrae should be used, 
but vertebrae that are affected by local structural change should be deleted from the 
analysis. Most agree that decisions can be based on two vertebrae; the use of a single 
vertebra is not recommended. If all vertebrae are affected, the spine should be reported as 
‘‘invalid,’’ with no BMD or T-score results given. Figure 2 and 3 show examples from 
common spine and hips scanning problems. 
Finally, physicians must keep in mind to actively look for secondary osteoporosis in front of 
low BMD value, either by thorough history taking or with biochemical studies before stating 
about post menopausal osteoporosis.  
6. Vertebral fracture assessment (VFA) 
For assessing vertebral heights (also called vertebral morphometry), a special software is 
used to determine vertebral body dimensions. The computer (with the help of the 
technologist) places points on the superior and inferior endplates of each vertebra. The 
vertebral heights are calculated and compared to each other as well as to the expected 
normal dimensions. With the advent of higher-resolution DXA systems, visual assessment 
of fractures is also possible from DXA-based lateral spine images (Figure 4). In this situation, 
the DXA system essentially functions as a digital X-ray imaging device. Visual assessment is 
performed from a computer monitor or high-resolution printout. To optimize the 
assessment, the use of high-definition dual-energy images has been recommended (Rea, Li 
et al. 2000; Chapurlat, Duboeuf et al. 2006; Olenginski, Newman et al. 2006). Using a DXA 
system for assessing vertebral fracture status has several advantages. The evaluation of 
spine fractures can be performed without a conventional lateral spine X-ray. This can be 
done at the same time and at the same place as the BMD measurement, with much less 
radiation than a conventional spine X-ray. Moreover, VFA is a technology for diagnosing 
vertebral fractures that may alter diagnostic classification, improve fracture risk stratification, 
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                                                        (a)                                                               (b) 
   
                                                  (c)                                                                           (d) 
 
(e) 
Fig. 2. Examples among some common spine scanning problems: (a) The spine is too close to 
the right side of the image (b) Vertebral levels are mis-identified (c) Metal button over L4 (d) 
Scoliosis, and osteophyte at L3–L4 (e) Laminectomy 
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                                                           (a)                                                      (b) 
   
                                                 (c)                                                                       (d) 
  
(e) 
Fig. 3. Examples among some common hip scanning problems: (a) The scan did not go far 
enough laterally and part of the femoral head is missing. (b) The femur is adducted (c) The 
femur is abducted (d) Suboptimal internal rotation (too much of the lesser trochanter is 
showing) (e) Abnormal bone (history of hip fracture and osteosynthesis) 
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and identify patients likely to benefit from pharmacological therapy who otherwise might 
not be treated(Olenginski, Newman et al. 2006; Roux, Fechtenbaum et al. 2007). Despite the 
apparent advantages, the future of VFA using DXA remains unclear. Skeletal radiologists 
have criticized the technique for being insensitive and inaccurate for detecting vertebral 
fractures in particular at the upper thoracic spine. A DXA image is of lower resolution than 
a conventional X-ray and might fail to identify other potential problems or diseases that 
would be apparent on a spine film. However, VFA allows ruling out vertebral fracture at 
levels where vertebral fracture is most common, i.e. the lumbar and the mid and lower 
thoracic levels, and the pencil beam mode of assessment eliminates parallax errors in 
viewing the vertebral body, which can sometimes make a normal vertebral body appear to 
have been compressed in a routine spine x-ray(Duboeuf, Bauer et al. 2005; Jacobs-Kosmin, 
Sandorfi et al. 2005; Chapurlat, Duboeuf et al. 2006; Damiano, Kolta et al. 2006). 
 
Fig. 4. Vertebral fracture assessment from a dual x-ray absorptiometry image of the spine. 
At this time, DXA devices are not generally accepted as a surrogate for spinal X-rays, 
though they may provide a useful screening tool in higher-risk patients when spinal X-rays 
are unavailable. For example, individuals over 65, subjects reporting significant height loss 
or patients on long term glucocorticoid therapy who have not had previous vertebral 
fractures or spinal radiographs could benefit from a VFA. 
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7. Concordance between measurement sites 
It is recommended to measure the PA lumbar spine and proximal femur and classifying 
the patient based on the lowest T-score from three sites (lumbar spine, femoral neck, and 
total hip). Although the BMDs at different anatomic regions are correlated, the agreement 
between sites is low when it comes to classifying individual subjects as osteoporotic or 
not. Thus, T-score discordance between the lumbar spine and hip testing sites is a 
commonly observed phenomenon in densitometery. T-score discordance is the 
observation that the T-score of an individual patient varies from one key measurement 
site to another.  
7.1 Prevalence and risk factors of T-score discordance  
Various studies have analyzed the prevalence and impact of T-score discordance on the 
management of osteoporosis(Faulkner, von Stetten et al. 1999; Woodson 2000; O'Gradaigh, 
Debiram et al. 2003; Moayyeri, Soltani et al. 2005). Only two studies focused on risk factors 
of this commonly observed discordance (Moayyeri, Soltani et al. 2005; El Maghraoui, 
Mouinga Abayi et al. 2007; El Maghraoui, Mouinga Abayi et al. 2007). Five different causes 
for occurrence of discordance between the spine and the hip sites have been 
described(Woodson 2000).  
1. Physiologic discordance is related to the skeleton's natural adaptive reaction to 
normal external and internal factors and forces. Mechanical strain especially related 
to weight bearing plays a key role in this kind of discordance. An example of this 
type of discordance is the difference observed between the dominant and non-
dominant total hip(Hamdy, Kiebzak et al. 2006). The explanation is that weight 
bearing can cause rise in bone density especially in the hip and femur regions. 
Moreover, the spine and hips usually start out with different T-scores (the spine is 
said to reach peak at least 5 yrs before the hip)(Blank, Malone et al. 2006). And finally, 
bone loss observed with age in an individual may be more rapid and important in 
trabecular than cortical bone is another explanation(Agarwal and Camacho 2006). 
Trabecular bones (typical of lumbar area) are known to have a more rapid rate of 
deprivation in early post-menopausal state in comparison to cortical bone (typical of 
proximal femur).  
2. The second type of discordance described as pathophysiologic discordance is seen 
secondary to a disease. Common examples observed in the elderly include vertebral 
osteophytosis, vertebral end plate and facet sclerosis, osteochondrosis, and aortic 
calcification(Bolotin 2001; Theodorou and Theodorou 2002). Another important cause 
in younger patients is ankylosing spondylitis syndesmophytes(El Maghraoui, 
Borderie et al. 1999; Maillefert, Aho et al. 2001; El Maghraoui 2004; El Maghraoui 
2004; El Maghraoui, Do Santos Zounon et al. 2005). The abnormal calcium deposition 
within the field of the DXA region of interest (ROI) leads to the falsely elevated spine 
T-score. A second subtype is a true discordance resulting from a more decreased 
BMD in the lumbar spine than the hips. Indeed, most of the aetiologies of the 
secondary osteoporosis (such as glucocorticoid excess, hyperthyroidism, 
malabsorption, liver disease, rheumatoid arthritis) first affect spinal column(El 
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Maghraoui 2004; Khan, Hanley et al. 2006). This will lead to higher prevalence of 
lumbar osteoporosis.  
3. Anatomic discordance is owing to differences in the composition of bone envelopes 
tested. An example is the difference in T-scores found for the posteroanterior lumbar 
spine and the supine lateral lumbar spine in the same patient.  
4. Artifactual discordance occurs when dense synthetic manmade substances are within 
the field of ROI of the test: e.g. barium sulphate, metal from zipper, coin, clip, or other 
metallic object.  
5. And finally, technical discordance occurs because of device errors, technician 
variability, patients’ movements, and variation due to other unpredictable sources. With 
respect to positioning error, some studies showed that either excessive internal or 
external rotation of the femur during test acquisition resulted in a BMD difference of as 
much as 10% compared with correct positioning. We demonstrated in a previous study 
that DXA in vivo reproducibility is two-fold better in the hips than the spine especially 
when measuring both hips(El Maghraoui, Do Santos Zounon et al. 2005). Finally, 
technical discordance can occur due to the normative reference data used by the device 
software to analyze the test(Liao, Wu et al. 2003; McMahon, Nightingale et al. 2004; 
Lewiecki, Binkley et al. 2006). This type of discordance occurs when the average BMD 
of the normative group used to calculate the T-score is significantly different from the 
average value found for the whole population.  
7.2 Consequences of T-score discordance on osteoporosis management 
The high prevalence of T-score discordance could induce some problems for the physicians 
in decision-making regarding these patients. In general, high prevalence of discordance 
between lumbar spine and hip T-scores suggests some defects in the cut-off values for 
definition of osteoporosis and osteopenia proposed with the WHO. The inconsistencies in 
the diagnostic classification of osteoporosis between skeletal sites lend credence to the 
notion that BMD should be used as only one of the factors in making therapeutic decisions 
when evaluating patients with osteoporosis. An international team convened by the WHO is 
trying to develop a globally applicable measure of absolute fracture risk based upon 
multiple risk factors including BMD. This could silence much of the controversy regarding 
the choice of reference data for T-score calculation and usefulness of relatively arbitrary 
densitometric categorizations. However, one can speculate that discordance in individual 
fracture risk estimation with this new absolute fracture risk will still be observed as it will be 
based on different sites BMD. 
8. Conclusion 
Correct performance of BMD measurements using DXA requires rigorous attention to detail 
in positioning and analysis. When DXA studies are performed incorrectly, it can lead to 
major mistakes in diagnosis and therapy. Measurement error must be considered when 
evaluating serial assessments. A clear understanding of the interpretation of serial 
measurements and the statistical principles impacting upon their interpretation is necessary 
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to determine whether a change is real and not simply random fluctuation. Moreover, it is 
important to keep in mind that fracture-protection benefit may be realized before BMD 
gains are detected. Physicians interested in osteoporosis management, even if not directly 
involved in the performance and interpretation of DXA, should be familiar with the 
principles outlined here to minimize serious errors and allow proper use of bone 
densitometry.  
9. Abbreviations 
BMC: bone mineral content 
BMD: bone mineral density 
CV: coefficient of variation 
DXA: dual-energy x-ray absorptiometry 
IOF: international osteoporosis foundation 
ISCD: international society for clinical densitometry 
LSC: least significant change 
OST: osteoporosis self-assessment tool 
PE: precision error 
ROI: region of interest 
SD: standard deviation 
SDD: smallest detectable difference 
VFA: vertebral fracture assessment 
WHO: world health organization 
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